Bank of America Corporation »

Brainstorm Cell Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $273 1.1k 0.26
2023-09-30 $200 1.0k 0.20
2023-06-30 $11k 5.2k 2.06
2023-03-31 $16k 4.9k 3.30
2022-12-31 $9.6k 5.8k 1.64
2022-06-30 $21k 7.6k 2.72
2021-12-31 $12k 3.1k 4.00
2021-06-30 $145k 36k 4.00
2021-03-31 $184k 48k 3.84
2020-12-31 $212k 47k 4.53
2020-09-30 $654k 39k 16.91
2020-06-30 $718k 64k 11.21
2020-03-31 $218k 47k 4.65
2019-12-31 $98k 23k 4.28
2019-09-30 $82k 21k 3.90
2019-03-31 $91k 21k 4.35
2018-12-31 $71k 20k 3.55
2018-06-30 $78k 20k 3.90
2018-03-31 $47k 15k 3.13
2017-12-31 $59k 15k 3.93
2017-09-30 $62k 15k 4.13
2017-03-31 $64k 15k 4.27
2016-12-31 $38k 15k 2.53
2016-09-30 $25k 10k 2.40
2016-06-30 $24k 10k 2.40
2014-09-30 $178k 43k 4.11